Erratum to: Cardioprotective and hepatoprotective effects of ellagitannins from European oak bark (Quercus petraea L.) extract in rats (Eur J Nutr, (2013), 52(1) (397-408), 10.1007/s00394-011-0277-1);Cardioprotective and hepatoprotective effects of ellagitannins from European oak bark (Quercus petraea L.) extract in rats

European Journal of Nutrition

Volumn 52, Issue 1, 2013, Pages 397-408

  Panchal, Sunil K ^a,b   Brown, Lindsay ^a,b  

^a UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cardiovascular disease; Dyslipidaemia; Ellagitannins; Hypertension; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; ELLAGITANNIN; LACTATE DEHYDROGENASE; UREA; URIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; FLOW RATE; HEART MUSCLE FIBROSIS; HEART PROTECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID DIET; LIVER PROTECTION; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONHUMAN; OAK; OXIDATIVE STRESS; QUERCUS PETRAEA; RAT; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 84872739322     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-012-0335-3     Document Type: Erratum

References (39)

1. Saucier C, Jourdes M, Glories Y, Quideau S (2006) Extraction, detection, and quantification of flavano-ellagitannins and ethylvescalagin in a Bordeaux red wine aged in oak barrels. J Agric Food Chem 54:7349-7354 (Pubitemid 44554962)
2. Garcia-Estevez I, Escribano-Bailon MT, Rivas-Gonzalo JC, Alcalde-Eon C (2010) Development of a fractionation method for the detection and identification of oak ellagitannins in red wines. Anal Chim Acta 660:171-176
3. Karonen M, Parker J, Agrawal A, Salminen JP (2010) First evidence of hexameric and heptameric ellagitannins in plants detected by liquid chromatography/electrospray ionisation mass spectrometry. Rapid Commun Mass Spectrom 24:3151-3156
4. Yoshida T, Amakura Y, Yoshimura M (2010) Structural features and biological properties of ellagitannins in some plant families of the order Myrtales. Int J Mol Sci 11:79-106
5. Cerda B, Tomas-Barberan FA, Espin JC (2005) Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability. J Agric Food Chem 53:227-235 (Pubitemid 40129908)
6. Bakkalbasi E, Mentes Ãz, Artik N (2009) Food ellagitannins- occurrence, effects of processing and storage. Crit Rev Food Sci Nutr 49:283-298
7. Puech JL, Mertz C, Michon V, Le Guerneve C, Doco T, Herve Du Penhoat C (1999) Evolution of castalagin and vescalagin in ethanol solutions. Identification of new derivatives. J Agric Food Chem 47:2060-2066 (Pubitemid 29438761)
8. Kroon PA, Iyer A, Chunduri P, Chan V, Brown L (2010) The cardiovascular nutrapharmacology of resveratrol: pharmacokinetics, molecular mechanisms and therapeutic potential. Curr Med Chem 17:2442-2455
9. Seeram NP, Henning SM, Zhang Y, Suchard M, Li Z, Heber D (2006) Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J Nutr 136:2481-2485 (Pubitemid 44521600)
10. Coates EM, Popa G, Gill CI, McCann MJ, McDougall GJ, Stewart D, Rowland I (2006) Colon-available raspberry polyphenols exhibit anti-cancer effects on in vitro models of colon cancer. J Carcinog 6:4
11. Basu A, Penugonda K (2009) Pomegranate juice: a heart-healthy fruit juice. Nutr Rev 67:49-56
12. Jadeja R, Thounaojam M, Patel D, Devkar R, Ramachandran A (2010) Pomegranate (Punica granatum L.) juice supplementation attenuates isoproterenol-induced cardiac necrosis in rats. Cardiovasc Toxicol 10:174-180
13. Mohan M, Waghulde H, Kasture S (2010) Effect of pomegranate juice on angiotensin II-induced hypertension in diabetic Wistar rats. Phytother Res 24:S196-S203
14. de Nigris F, Balestrieri ML, Williams-Ignarro S, D'Armiento FP, Fiorito C, Ignarro LJ, Napoli C (2007) The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. Nitric Oxide 17:50-54 (Pubitemid 47064428)
15. Seeram NP, Lee R, Heber D (2004) Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clinica Chimica Acta 348:63-68 (Pubitemid 39209002)
16. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747-1757 (Pubitemid 43767064)
17. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome-a new worldwide definition. Lancet 366:1059-1062 (Pubitemid 41338752)
18. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, Tiribelli C (2000) Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132:112-117 (Pubitemid 30044177)
19. Doggrell SA, Brown L (1998) Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res 39:89-105 (Pubitemid 28322382)
20. Panchal SK, Poudyal H, Iyer A, Nazer R, Alam MA, Diwan V, Kauter K, Sernia C, Campbell F et al (2011) High-carbohydrate high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol 57:611-624
21. Panchal SK, Brown L (2011) Rodent models for metabolic syndrome research. J Biomed Biotechnol 2011:351982
22. Chan V, Fenning A, Levick SP, Loch D, Chunduri P, Iyer A, Teo YL, Hoey A, Wilson K et al (2011) Cardiovascular changes during maturation and ageing in male and female Spontaneously Hypertensive Rats. J Cardiovasc Pharmacol 57:469-478
23. Poudyal H, Campbell F, Brown L (2010) Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. J Nutr 140:946-953
24. Sim AS, Salonikas C, Naidoo D, Wilcken DE (2003) Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard. J Chromatogr B Anal Technol Biomed Life Sci 785:337-344 (Pubitemid 36126174)
25. Lexis LA, Fenning A, Brown L, Fassett RG, Coombes JS (2006) Antioxidant supplementation enhances erythrocyte antioxidant status and attenuates cyclosporine-induced vascular dysfunction. Am J Transpl 6:41-49 (Pubitemid 43382199)
26. Bertelli AA, Das DK (2009) Grapes, wines, resveratrol, and heart health. J Cardiovasc Pharmacol 54:468-476
27. Waterhouse AL (2002) Wine phenolics. Ann N Y Acad Sci 957:21-36 (Pubitemid 34721651)
28. Cerda B, Ceron JJ, Tomas-Barberan FA, Espin JC (2003) Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. J Agric Food Chem 51:3493-3501
29. Seeram NP, Lee R, Heber D (2004) Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clin Chim Acta 348:63-68 (Pubitemid 39209002)
30. Cerda B, Llorach R, Ceron JJ, Espin JC, Tomas-Barberan FA (2003) Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. Eur J Nutr 42:18-28 (Pubitemid 36286302)
31. Panchal SK, Poudyal H, Arumugam TV, Brown L (2011) Rutin attenuates metabolic changes, non-alcoholic steatohepatitis, and cardiovascular remodeling in high carbohydrate-, high-fat diet-fed rats. J Nutr 141:1062-1069
32. Poudyal H, Panchal S, Brown L (2010) Comparison of purple carrot juice and beta-carotene in a high-carbohydrate, high-fat diet-fed rat model of the metabolic syndrome. Br J Nutr 104:1322-1332
33. Poudyal H, Panchal SK, Waanders J, Ward L, Brown L (2011) Lipid redistribution by α-linolenic acid-rich chia seed inhibits stearoyl-CoA desaturase-1 and induces cardiac and hepatic protection in diet-induced obese rats. J Nutr Biochem. doi: 10.1016/j.jnutbio.2010.11.011
34. Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D (2005) In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 16:360-367 (Pubitemid 40776045)
35. Larrosa M, Gonzalez-Sarrias A, Yanez-Gascon MJ, Selma MV, Azorin-Ortuno M, Toti S, Tomas-Barberan F, Dolara P, Espin JC (2010) Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J Nutr Biochem 21:717-725
36. de Nigris F, Williams-Ignarro S, Sica V, Lerman LO, D'Armiento FP, Byrns RE, Casamassimi A, Carpentiero D, Schiano C et al (2007) Effects of a pomegranate fruit extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis. Cardiovasc Res 73:414-423 (Pubitemid 44937691)
37. Shukla M, Gupta K, Rasheed Z, Khan KA, Haqqi TM (2008) Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis. Nutrition 24:733-743
38. Lei F, Zhang XN, Wang W, Xing DM, Xie WD, Su H, Du LJ (2007) Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice. Int J Obes (Lond) 31:1023-1029 (Pubitemid 46842679)
39. Iyer A, Brown L (2010) Lipid mediators and inflammation in glucose intolerance and insulin resistance. Drug Discov Today Dis Mech 7(3-4):e191-e197